A Late-Stage Alzheimer’s Trial Gave Them Hope—Until It Was Canceled
Jeff Borghoff and his wife Kimberly speak about participating in the Biogen drug trial testing aducanumab, a drug that targets beta-amyloid. The late-stage trial was recently canceled, news that sent participants, their families, researchers and stocks reeling.
[ Next: ‘They Are Still Here, and They Can Still Contribute’: What He Learned From Alzheimer’s at Age 51 ]
Thank you Deborah Kan and Being Patient for allowing Kim and I to tell our story about our clinical trial experience.